Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer

Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer

Neoadjuvant chemotherapy (NACT) is used in locally advanced breast cancer to reduce tumour burden prior to surgical resection. However, only a subset of NACT treated patients will respond to treatment or achieve a pathologic complete response (pCR). This multicenter, prospective study (CTRIAL-IE (IC...

Full description

Bibliographic Details
Main Authors: Andrew McGuire, Maire-Caitlin Casey, Ronan M. Waldron, Helen Heneghan, Olga Kalinina, Emma Holian, Ailbhe McDermott, Aoife J. Lowery, John Newell, Róisín M. Dwyer, Nicola Miller, Maccon Keane, James A.L. Brown, Michael J. Kerin
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
breast
microRNA
neoadjuvant
chemotherapy
prognostic
biomarker
Online Access:https://www.mdpi.com/2072-6694/12/7/1820

Internet

https://www.mdpi.com/2072-6694/12/7/1820

Similar Items